Amarin Corporation plc (AMRN)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.5400 |
| Open | 1.5500 |
| Bid | 1.5400 x 21500 |
| Ask | 1.5000 x 4000 |
| Day's range | 1.4150 - 1.5450 |
| 52-week range | 1.0400 - 3.7400 |
| Volume | |
| Avg. volume | 4,669,972 |
| Market cap | 605.743M |
| Beta (5Y monthly) | 1.91 |
| PE ratio (TTM) | 750.00 |
| EPS (TTM) | 0.0020 |
| Earnings date | 01 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.57 |
- Zacks
Amarin's (AMRN) Q4 Earnings and Revenues Beat Estimates
Amarin Corporation's (AMRN) fourth-quarter 2022 earnings and revenues beat estimates; Vascepa sales decline.
- Zacks
Jazz's (JAZZ) Q4 Earnings Miss Estimates, New Drugs Drive Sales
Jazz (JAZZ) reports dismal fourth-quarter results as earnings and sales miss expectations. Sleep disorder drug Xywav become the company's largest product by net sales during the quarter.
- Simply Wall St.
Amarin Full Year 2022 Earnings: US$0.26 loss per share (vs US$0.02 profit in FY 2021)
Amarin ( NASDAQ:AMRN ) Full Year 2022 Results Key Financial Results Revenue: US$369.2m (down 37% from FY 2021). Net...
© 2023 Yahoo. All rights reserved.
